{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:31:49Z","timestamp":1790681509056,"version":"4.1.0"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.lfs.2020.118934","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T16:50:05Z","timestamp":1609260605000},"page":"118934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Therapeutic targets of cancer drugs: Modulation by melatonin"],"prefix":"10.1016","volume":"267","author":[{"given":"Milad","family":"Moloudizargari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Moradkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Hekmatirad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Fallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Asghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russel J.","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118934_bb0005","doi-asserted-by":"crossref","unstructured":"R.J. Reiter, Pineal melatonin: cell biology of its synthesis and of its physiological interactions, Endocr. Rev.. 12 (1991) 151\u201380, doi:https:\/\/doi.org\/10.1210\/edrv-12-2-151.","DOI":"10.1210\/edrv-12-2-151"},{"key":"10.1016\/j.lfs.2020.118934_bb0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10409230903044914","article-title":"Reducing oxidative\/nitrosative stress: a newly-discovered genre for melatonin","volume":"44","author":"Reiter","year":"2009","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.lfs.2020.118934_bb0015","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s00018-014-1579-2","article-title":"Extrapineal melatonin: sources, regulation, and potential functions","volume":"71","author":"Acuna-Castroviejo","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2020.118934_bb0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/jpi.12026","article-title":"Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin\u2019s primary function and evolution in eukaryotes","volume":"54","author":"Tan","year":"2013","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.32794\/mr11250033","article-title":"Inhibition of mitochondrial pyruvate dehydrogenase kinase: a proposed mechanism by which melatonin causes cancer cells to overcome cytosolic glycolysis, reduce tumor biomass and reverse insensitivity to chemotherapy","volume":"2","author":"Reiter","year":"2019","journal-title":"Melatonin Research"},{"key":"10.1016\/j.lfs.2020.118934_bb0030","doi-asserted-by":"crossref","unstructured":"R.J. Reiter, R. Sharma, Q. Ma, S. Rorsales-Corral, L.G. de Almeida Chuffa, Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: a mechanistic hypothesis, Cell. Mol. Life Sci.. (2020) 1\u201316, doi:https:\/\/doi.org\/10.1007\/s00018-019-03438-1.","DOI":"10.1007\/s00018-019-03438-1"},{"key":"10.1016\/j.lfs.2020.118934_bb0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1152\/physiol.00034.2019","article-title":"Melatonin in mitochondria: mitigating clear and present dangers","volume":"35","author":"Reiter","year":"2020","journal-title":"Physiology"},{"key":"10.1016\/j.lfs.2020.118934_bb0040","doi-asserted-by":"crossref","first-page":"362","DOI":"10.32794\/mr11250068","article-title":"Plasticity of glucose metabolism in activated immune cells: advantages for melatonin inhibition of COVID-19 disease","volume":"3","author":"Reiter","year":"2020","journal-title":"Melatonin Research"},{"key":"10.1016\/j.lfs.2020.118934_bb0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-079X.2011.00856.x","article-title":"A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases","volume":"51","author":"Stehle","year":"2011","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-079X.2011.00931.x","article-title":"Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations","volume":"52","author":"Venegas","year":"2012","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0055","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/1871527313666140711091400","article-title":"Local melatonin regulates inflammation resolution: a common factor in neurodegenerative, psychiatric and systemic inflammatory disorders","volume":"13","author":"Anderson","year":"2014","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.lfs.2020.118934_bb0060","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1007\/s00204-017-1998-6","article-title":"On the mechanisms of melatonin in protection of aluminum phosphide cardiotoxicity","volume":"91","author":"Asghari","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.lfs.2020.118934_bb0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/ENDO:27:2:189","article-title":"A review of the multiple actions of melatonin on the immune system","volume":"27","author":"Carrillo-Vico","year":"2005","journal-title":"Endocrine"},{"key":"10.1016\/j.lfs.2020.118934_bb0070","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1467-789X.2010.00756.x","article-title":"Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity","volume":"12","author":"Tan","year":"2011","journal-title":"Obes. Rev."},{"key":"10.1016\/j.lfs.2020.118934_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-079X.2011.00916.x","article-title":"Melatonin as a natural ally against oxidative stress: a physicochemical examination","volume":"51","author":"Galano","year":"2011","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0080","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1600-079X.2010.00759.x","article-title":"Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease","volume":"48","author":"Paradies","year":"2010","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/17425255.2016.1214712","article-title":"A review of the protective effect of melatonin in pesticide-induced toxicity","volume":"13","author":"Asghari","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.lfs.2020.118934_bb0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-079X.2010.00812.x","article-title":"Matrix metalloproteinases in health and disease: regulation by melatonin","volume":"50","author":"Swarnakar","year":"2011","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0095","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/carcin\/bgn115","article-title":"Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer","volume":"29","author":"Rodriguez","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2020.118934_bb0100","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/jcp.29036","article-title":"Immunoregulatory role of melatonin in cancer","volume":"235","author":"Moradkhani","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2020.118934_bb0105","unstructured":"R. Girgert, C. Bartsch, S.M. Hill, R. Kreienberg, V. Hanf, Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach, Neuro Endocrinol Lett. 24 (2003) 440\u20134."},{"key":"10.1016\/j.lfs.2020.118934_bb0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1034\/j.1600-079X.2000.280403.x","article-title":"Differential responsiveness of MCF-7 human breast cancer cell line stocks to the pineal hormone, melatonin","volume":"28","author":"Ram","year":"2000","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0115","doi-asserted-by":"crossref","unstructured":"S.M. Hill, T. Frasch, S. Xiang, L. Yuan, T. Duplessis, L. Mao, Molecular mechanisms of melatonin anticancer effects, Integr Cancer Ther. 8 (2009) 337\u2013346, doi:https:\/\/doi.org\/10.1177\/1534735409353332.","DOI":"10.1177\/1534735409353332"},{"key":"10.1016\/j.lfs.2020.118934_bb0120","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1158\/0008-5472.CAN-05-1945","article-title":"Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats","volume":"65","author":"Blask","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0125","doi-asserted-by":"crossref","unstructured":"H. Qu, Y. Xue, W. Lian, C. Wang, J. He, Q. Fu, L. Zhong, N. Lin, L. Lai, Z. Ye, Q. Wang, Melatonin inhibits osteosarcoma stem cells by suppressing SOX9-mediated signaling, Endocrine. 207 (2018) 253\u2013264, doi:https:\/\/doi.org\/10.1007\/s12020-018-1624-2.","DOI":"10.1016\/j.lfs.2018.04.030"},{"key":"10.1016\/j.lfs.2020.118934_bb0130","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0959-8049(99)00159-8","article-title":"Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status","volume":"35","author":"Lissoni","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lfs.2020.118934_bb0135","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1211\/002235702760345374","article-title":"Melatonin: reducing the toxicity and increasing the efficacy of drugs","volume":"54","author":"Reiter","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118934_bb0140","doi-asserted-by":"crossref","unstructured":"P.F. Innominato, V.P. Roche, O.G. Palesh, A. Ulusakarya, D. Spiegel, F.A. Levi, The circadian timing system in clinical oncology, Ann. Med.. 46 (2014) 191\u2013207, doi:https:\/\/doi.org\/10.3109\/07853890.2014.916990.","DOI":"10.3109\/07853890.2014.916990"},{"key":"10.1016\/j.lfs.2020.118934_bb0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.lfs.2017.07.020","article-title":"Melatonin as a multifunctional anti-cancer molecule: implications in gastric cancer","volume":"185","author":"Asghari","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.118934_bb0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.patbio.2006.12.025","article-title":"Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms","volume":"55","author":"Lissoni","year":"2007","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.lfs.2020.118934_bb0155","doi-asserted-by":"crossref","unstructured":"R. Sainz, J. Mayo, C. Rodriguez, D. Tan, S. Lopez-Burillo, R. Reiter, Melatonin and cell death: differential actions on apoptosis in normal and cancer cells, Cellular and Molecular Life Sciences CMLS. 60 (2003) 1407\u20131426, doi:https:\/\/doi.org\/10.1007\/s00018-003-2319-1.","DOI":"10.1007\/s00018-003-2319-1"},{"key":"10.1016\/j.lfs.2020.118934_bb0160","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.lfs.2019.05.009","article-title":"Modulation of apoptosis by melatonin for improving cancer treatment efficiency: an updated review","volume":"228","author":"Mortezaee","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.118934_bb0165","doi-asserted-by":"crossref","unstructured":"A. Kocyigit, E.M. Guler, E. Karatas, H. Caglar, H. Bulut, Dose-dependent proliferative and cytotoxic effects of melatonin on human epidermoid carcinoma and normal skin fibroblast cells, Mutation Research\/Genetic Toxicology and Environmental Mutagenesis. 829 (2018) 50\u201360, doi:https:\/\/doi.org\/10.1016\/j.mrgentox.2018.04.002.","DOI":"10.1016\/j.mrgentox.2018.04.002"},{"key":"10.1016\/j.lfs.2020.118934_bb0170","doi-asserted-by":"crossref","unstructured":"C. Godson, S.M. Reppert, The Mel1a melatonin receptor is coupled to parallel signal transduction pathways, Endocrinology. 138 (1997) 397\u2013404, doi:https:\/\/doi.org\/10.1210\/endo.138.1.4824.","DOI":"10.1210\/en.138.1.397"},{"key":"10.1016\/j.lfs.2020.118934_bb0175","doi-asserted-by":"crossref","unstructured":"L. Brydon, F. Roka, L. Petit, P. de Coppet, M. Tissot, P. Barrett, P.J. Morgan, C. Nanoff, A.D. Strosberg, R. Jockers, Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q\/11) proteins, Mol. Endocrinol.. 13 (1999) 2025\u201338, doi:https:\/\/doi.org\/10.1210\/mend.13.12.0390.","DOI":"10.1210\/mend.13.12.0390"},{"key":"10.1016\/j.lfs.2020.118934_bb0180","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1074\/jbc.270.13.7037","article-title":"The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes","volume":"270","author":"Steinhilber","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118934_bb0185","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/modpathol.3800621","article-title":"Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis","volume":"19","author":"Reis-Filho","year":"2006","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lfs.2020.118934_bb0190","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-14-0816","article-title":"Molecular pathways: targeting the cyclin D-CDK4\/6 Axis for cancer treatment","volume":"21","author":"VanArsdale","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2020.118934_bb0200","doi-asserted-by":"crossref","unstructured":"J. Hulit, C. Wang, Z. Li, C. Albanese, M. Rao, D. Di Vizio, S. Shah, S.W. Byers, R. Mahmood, L.H. Augenlicht, Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice, Mol. Cell. Biol.. 24 (2004) 7598\u20137611, doi:10.1128\/MCB.24.17.7598\u20137611.2004.","DOI":"10.1128\/MCB.24.17.7598-7611.2004"},{"key":"10.1016\/j.lfs.2020.118934_bb0205","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1053\/gast.1996.v110.pm8608874","article-title":"Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis","volume":"110","author":"Arber","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2020.118934_bb0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccr.2005.12.019","article-title":"Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis","volume":"9","author":"Landis","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2020.118934_bb0215","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/jcp.21791","article-title":"Nuclear cyclin D1: an oncogenic driver in human cancer","volume":"220","author":"Kim","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2020.118934_bb0220","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrclinonc.2016.26","article-title":"Treating cancer with selective CDK4\/6 inhibitors","volume":"13","author":"O\u2019Leary","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lfs.2020.118934_bb0225","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/bjc.2017.288","article-title":"Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies","volume":"117","author":"Mita","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2020.118934_bb0230","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.clml.2015.02.021","article-title":"A phase II, single-arm, open-label, multicenter study to evaluate the efficacy and safety of P276-00, a cyclin-dependent kinase inhibitor, in patients with relapsed or refractory mantle cell lymphoma","volume":"15","author":"Cassaday","year":"2015","journal-title":"Clinical lymphoma, myeloma & leukemia"},{"key":"10.1016\/j.lfs.2020.118934_bb0235","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.steroids.2010.06.002","article-title":"Melatonin inhibits mitogenic cross-talk between retinoic acid-related orphan receptor alpha (RORalpha) and ERalpha in MCF-7 human breast cancer cells","volume":"75","author":"Dong","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.lfs.2020.118934_bb0240","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1159\/000447922","article-title":"Inhibition of ERK1\/2 signaling pathway is involved in melatonin\u2019s antiproliferative effect on human MG-63 osteosarcoma cells","volume":"39","author":"Liu","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2020.118934_bb0245","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/jpi.12119","article-title":"Melatonin treatment induces interplay of apoptosis, autophagy, and senescence in human colorectal cancer cells","volume":"56","author":"Hong","year":"2014","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0250","article-title":"Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.118934_bb0255","doi-asserted-by":"crossref","first-page":"21342","DOI":"10.1039\/C7RA02113E","article-title":"Melatonin enhances the anti-tumor effect of sorafenib via AKT\/p27-mediated cell cycle arrest in hepatocarcinoma cell lines","volume":"7","author":"Long","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.lfs.2020.118934_bb0260","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.canlet.2009.06.016","article-title":"Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death","volume":"287","author":"Mart\u00edn","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2020.118934_bb0265","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-079X.2007.00548.x","article-title":"The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes","volume":"45","author":"Pizarro","year":"2008","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0270","doi-asserted-by":"crossref","unstructured":"J.H. Jung, E.J. Sohn, E.A. Shin, D. Lee, B. Kim, D.-B. Jung, J.-H. Kim, M. Yun, H.-J. Lee, Y.K. Park, S.-H. Kim, Melatonin suppresses the expression of 45S preribosomal RNA and upstream binding factor and enhances the antitumor activity of puromycin in MDA-MB-231 breast cancer cells, Evid. Based Complement. Alternat. Med. 2013 (2013) 879746\u2013879746, doi:https:\/\/doi.org\/10.1155\/2013\/879746.","DOI":"10.1155\/2013\/879746"},{"key":"10.1016\/j.lfs.2020.118934_bb0275","doi-asserted-by":"crossref","unstructured":"A.M. Senderowicz, Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials, Investig. New Drugs 17 (1999) 313\u2013320, doi:https:\/\/doi.org\/10.1023\/A:1006353008903.","DOI":"10.1023\/A:1006353008903"},{"key":"10.1016\/j.lfs.2020.118934_bb0280","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/cam4.1970","article-title":"Safety and efficacy profile of cyclin-dependent kinases 4\/6 inhibitor palbociclib in cancer therapy: a meta-analysis of clinical trials","volume":"8","author":"Guo","year":"2019","journal-title":"Cancer medicine"},{"key":"10.1016\/j.lfs.2020.118934_bb0285","doi-asserted-by":"crossref","unstructured":"B. Hoesel, J.A. Schmid, The complexity of NF-kappaB signaling in inflammation and cancer, Mol. Cancer. 12 (2013) 86, doi:https:\/\/doi.org\/10.1186\/1476-4598-12-86.","DOI":"10.1186\/1476-4598-12-86"},{"key":"10.1016\/j.lfs.2020.118934_bb0290","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12079-011-0121-7","article-title":"Proteasome inhibitors in cancer therapy","volume":"5","author":"Crawford","year":"2011","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.lfs.2020.118934_bb0295","doi-asserted-by":"crossref","unstructured":"J. Ling, Y. Kang, R. Zhao, Q. Xia, D.F. Lee, Z. Chang, J. Li, B. Peng, J.B. Fleming, H. Wang, J. Liu, I.R. Lemischka, M.C. Hung, P.J. Chiao, KrasG12D-induced IKK2\/beta\/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma, Cancer Cell. 21 (2012) 105\u2013120, doi:https:\/\/doi.org\/10.1016\/j.ccr.2011.12.006.","DOI":"10.1016\/j.ccr.2011.12.006"},{"key":"10.1016\/j.lfs.2020.118934_bb0300","doi-asserted-by":"crossref","unstructured":"D.G. Pfister, J.A. Fagin, Refractory thyroid cancer: a paradigm shift in treatment is not far off, J. Clin. Oncol.. 26 (2008) 4701\u20134, doi:https:\/\/doi.org\/10.1200\/jco.2008.17.3682.","DOI":"10.1200\/JCO.2008.17.3682"},{"key":"10.1016\/j.lfs.2020.118934_bb0305","doi-asserted-by":"crossref","unstructured":"C. Durante, N. Haddy, E. Baudin, S. Leboulleux, D. Hartl, J.P. Travagli, B. Caillou, M. Ricard, J.D. Lumbroso, F. De Vathaire, M. Schlumberger, Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy, J. Clin. Endocrinol. Metab.. 91 (2006) 2892\u20132899, doi:https:\/\/doi.org\/10.1210\/jc.2005-2838.","DOI":"10.1210\/jc.2005-2838"},{"key":"10.1016\/j.lfs.2020.118934_bb0310","doi-asserted-by":"crossref","unstructured":"F. Pacifico, A. Leonardi, Role of NF-kappaB in thyroid cancer, Mol. Cell. Endocrinol.. 321 (2010) 29\u201335, doi:https:\/\/doi.org\/10.1016\/j.mce.2009.10.010.","DOI":"10.1016\/j.mce.2009.10.010"},{"key":"10.1016\/j.lfs.2020.118934_bb0315","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/jpi.12293","article-title":"Melatonergic system-based two-gene index is prognostic in human gliomas","volume":"60","author":"Kinker","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0320","doi-asserted-by":"crossref","unstructured":"Y. Bu, G. Cai, Y. Shen, C. Huang, X. Zeng, Y. Cao, C. Cai, Y. Wang, D. Huang, D.F. Liao, D. Cao, Targeting NF-kappaB RelA\/p65 phosphorylation overcomes RITA resistance, Cancer Lett.. 383 (2016) 261\u2013271, doi:https:\/\/doi.org\/10.1016\/j.canlet.2016.10.006.","DOI":"10.1016\/j.canlet.2016.10.006"},{"key":"10.1016\/j.lfs.2020.118934_bb0325","doi-asserted-by":"crossref","unstructured":"Y.X. Lu, H.Q. Ju, F. Wang, L.Z. Chen, Q.N. Wu, H. Sheng, H.Y. Mo, Z.Z. Pan, D. Xie, T.B. Kang, G. Chen, J.P. Yun, Z.L. Zeng, R.H. Xu, Inhibition of the NF-kappaB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis, Cancer Lett.. 380 (2016) 87\u201397, doi:https:\/\/doi.org\/10.1016\/j.canlet.2016.06.014.","DOI":"10.1016\/j.canlet.2016.06.014"},{"key":"10.1016\/j.lfs.2020.118934_bb0330","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/jpi.12285","article-title":"Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-kappaB activation","volume":"60","author":"Ju","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0335","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.lfs.2018.01.024","article-title":"Does the use of melatonin overcome drug resistance in cancer chemotherapy?","volume":"196","author":"Asghari","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.118934_bb0340","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.redox.2018.02.025","article-title":"Melatonin suppresses thyroid cancer growth and overcomes radioresistance via inhibition of p65 phosphorylation and induction of ROS","volume":"16","author":"Zou","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2020.118934_bb0345","doi-asserted-by":"crossref","unstructured":"S. Shrestha, J. Zhu, Q. Wang, X. Du, F. Liu, J. Jiang, J. Song, J. Xing, D. Sun, Q. Hou, Y. Peng, J. Zhao, X. Sun, X. Song, Melatonin potentiates the antitumor effect of curcumin by inhibiting IKKbeta\/NF-kappaB\/COX-2 signaling pathway, Int. J. Oncol.. 51 (2017) 1249\u20131260, doi:https:\/\/doi.org\/10.3892\/ijo.2017.4097.","DOI":"10.3892\/ijo.2017.4097"},{"key":"10.1016\/j.lfs.2020.118934_bb0350","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3892\/ol.2014.2660","article-title":"Effect of Cnidii Rhizoma on nitric oxide production and invasion of human colorectal adenocarcinoma HT-29 cells","volume":"9","author":"Nam","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2020.118934_bb0355","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.3892\/or.2016.5100","article-title":"Melatonin induces cell apoptosis in Mia PaCa-2 cells via the suppression of nuclear factor-kappaB and activation of ERK and JNK: a novel therapeutic implication for pancreatic cancer","volume":"36","author":"Li","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2020.118934_bb0360","doi-asserted-by":"crossref","first-page":"e2371","DOI":"10.1038\/cddis.2016.256","article-title":"miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathways","volume":"7","author":"Fang","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2020.118934_bb0365","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.18632\/oncotarget.6407","article-title":"Melatonin inhibits AP-2beta\/hTERT, NF-kappaB\/COX-2 and Akt\/ERK and activates caspase\/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells","volume":"7","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.118934_bb0370","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1159\/000438587","article-title":"Melatonin induces cell apoptosis in AGS cells through the activation of JNK and P38 MAPK and the suppression of nuclear factor-kappa B: a novel therapeutic implication for gastric cancer","volume":"37","author":"Li","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2020.118934_bb0375","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/imm.12283","article-title":"Platelet-activating factor enhances tumour metastasis via the reactive oxygen species-dependent protein kinase casein kinase 2-mediated nuclear factor-kappaB activation","volume":"143","author":"Kim","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.lfs.2020.118934_bb0380","doi-asserted-by":"crossref","unstructured":"X. Wang, B. Wang, J. Xie, D. Hou, H. Zhang, H. Huang, Melatonin inhibits epithelialtomesenchymal transition in gastric cancer cells via attenuation of IL1beta\/NFkappaB\/MMP2\/MMP9 signaling, Int. J. Mol. Med. 42 (2018) 2221\u20132228, doi:https:\/\/doi.org\/10.3892\/ijmm.2018.3788.","DOI":"10.3892\/ijmm.2018.3788"},{"key":"10.1016\/j.lfs.2020.118934_bb0385","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.lfs.2017.07.020","article-title":"Melatonin as a multifunctional anti-cancer molecule: implications in gastric cancer","volume":"185","author":"Asghari","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.118934_bb0390","doi-asserted-by":"crossref","unstructured":"J.H. Lee, C.W. Yun, Y.S. Han, S. Kim, D. Jeong, H.Y. Kwon, H. Kim, M.J. Baek, S.H. Lee, Melatonin and 5-fluorouracil co-suppress colon cancer stem cells by regulating cellular prion protein-Oct4 axis, J. Pineal Res.. 65 (2018) e12519, doi:https:\/\/doi.org\/10.1111\/jpi.12519.","DOI":"10.1111\/jpi.12519"},{"key":"10.1016\/j.lfs.2020.118934_bb0395","doi-asserted-by":"crossref","unstructured":"D.-d. Xu, P.-j. Zhou, Y. Wang, Y. Zhang, R. Zhang, L. Zhang, S.-h. Chen, W.-y. Fu, B.-b. Ruan, H.-p. Xu, miR-150 suppresses the proliferation and tumorigenicity of leukemia stem cells by targeting the nanog signaling pathway, Front. Pharmacol.. 7 (2016) 439, doi:https:\/\/doi.org\/10.3389\/fphar.2016.00439.","DOI":"10.3389\/fphar.2016.00439"},{"key":"10.1016\/j.lfs.2020.118934_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099943","article-title":"Melatonin enhances the anti-tumor effect of fisetin by inhibiting COX-2\/iNOS and NF-kappaB\/p300 signaling pathways","volume":"9","author":"Yi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118934_bb0405","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1600-079X.2010.00795.x","article-title":"Signal transduction of receptor-mediated antiproliferative action of melatonin on human prostate epithelial cells involves dual activation of G\u03b1s and G\u03b1q proteins","volume":"49","author":"Shiu","year":"2010","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0410","volume":"18","author":"Liu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2020.118934_bb0415","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrm1492","article-title":"Pathways of chaperone-mediated protein folding in the cytosol","volume":"5","author":"Young","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.lfs.2020.118934_bb0420","first-page":"89","article-title":"Heat shock proteins in oncology: diagnostic biomarkers or therapeutic targets?","volume":"1816","author":"Khalil","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2020.118934_bb0425","doi-asserted-by":"crossref","unstructured":"G. Jego, A. Hazoume, R. Seigneuric, C. Garrido, Targeting heat shock proteins in cancer, Cancer Lett.. 332 (2013) 275\u2013285, doi:https:\/\/doi.org\/10.1016\/j.canlet.2010.10.014.","DOI":"10.1016\/j.canlet.2010.10.014"},{"key":"10.1016\/j.lfs.2020.118934_bb0430","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1073\/pnas.1017909109","article-title":"Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer","volume":"109","author":"Straume","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2020.118934_bb0435","doi-asserted-by":"crossref","first-page":"25088","DOI":"10.1074\/jbc.M701740200","article-title":"Binding of caspase-3 prodomain to heat shock protein 27 regulates monocyte apoptosis by inhibiting caspase-3 proteolytic activation","volume":"282","author":"Voss","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118934_bb0440","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.biocel.2012.04.002","article-title":"Small heat shock proteins HSP27 (HspB1), alphaB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death","volume":"44","author":"Acunzo","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2020.118934_bb0445","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-079X.2011.00935.x","article-title":"Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK\/p90 ribosomal S6 kinase\/heat shock protein 27 in SK-OV-3 cells","volume":"52","author":"Kim","year":"2012","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0450","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118934_bb0455","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1158\/0008-5472.CAN-15-3278","article-title":"DNA methylation in cancer and aging","volume":"76","author":"Klutstein","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0460","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/ng.3291","article-title":"Whole-genome fingerprint of the DNA methylome during human B cell differentiation","volume":"47","author":"Kulis","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lfs.2020.118934_bb0465","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/07420528.2013.842925","article-title":"Light at night and melatonin have opposite effects on breast cancer tumors in mice assessed by growth rates and global DNA methylation","volume":"31","author":"Schwimmer","year":"2014","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.lfs.2020.118934_bb0470","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.4161\/cc.5.19.3340","article-title":"Epigenetic activation of tumor suppressor microRNAs in human cancer cells","volume":"5","author":"Saito","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.lfs.2020.118934_bb0475","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/jnci\/dji311","article-title":"DNA methyltransferase inhibitors and the development of epigenetic cancer therapies","volume":"97","author":"Lyko","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2020.118934_bb0480","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-079X.2006.00407.x","article-title":"One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?","volume":"42","author":"Tan","year":"2007","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0485","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-079X.2007.00443.x","article-title":"Matrix metalloproteinase-9 activity and expression is reduced by melatonin during prevention of ethanol-induced gastric ulcer in mice","volume":"43","author":"Swarnakar","year":"2007","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0490","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.mehy.2004.12.014","article-title":"Melatonin seems to be a mediator that transfers the environmental stimuli to oocytes for inheritance of adaptive changes through epigenetic inheritance system","volume":"64","author":"Irmak","year":"2005","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.lfs.2020.118934_bb0495","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1600-079X.2012.01027.x","article-title":"Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin","volume":"54","author":"Lee","year":"2013","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0500","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-008-0103-5","article-title":"Role of melatonin in the epigenetic regulation of breast cancer","volume":"115","author":"Korkmaz","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.lfs.2020.118934_bb0505","doi-asserted-by":"crossref","unstructured":"S. Takashi, I. Akio, M. Yasuhiro, M. Takuya, A. Jun-ichi, I. Takanori, H. Hisashi, Y. Yuri, H. Shin-ichi, S. Hironobu, Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor, Endocr. Relat. Cancer. 14 (2007) 279\u2013292, doi:https:\/\/doi.org\/10.1677\/ERC-06-0005.","DOI":"10.1677\/ERC-06-0005"},{"key":"10.1016\/j.lfs.2020.118934_bb0510","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.fertnstert.2007.03.078","article-title":"An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells","volume":"89","author":"Izawa","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.lfs.2020.118934_bb0515","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/bjc.2013.188","article-title":"Melatonin-induced methylation of the ABCG2\/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells","volume":"108","author":"Martin","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2020.118934_bb0520","unstructured":"P.N. Shah, M.C. Mhatre, L.S. Kothari, Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods, Cancer Res. 44 (1984) 3403\u20137."},{"key":"10.1016\/j.lfs.2020.118934_bb0525","unstructured":"S.M. Hill, D.E. Blask, Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture, Cancer Res. 48 (1988) 6121\u20136."},{"key":"10.1016\/j.lfs.2020.118934_bb0530","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1158\/0008-5472.CAN-13-3156","article-title":"Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer","volume":"74","author":"Dauchy","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0535","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40520-013-0118-6","article-title":"Update on the role of melatonin in the prevention of cancer tumorigenesis and in the management of cancer correlates, such as sleep-wake and mood disturbances: review and remarks","volume":"25","author":"Rondanelli","year":"2013","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0540","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-079X.1991.tb00007.x","article-title":"Effects of melatonin on the cell cycle kinetics and \u201cestrogen-rescue\u201d of MCF-7 human breast cancer cells in culture","volume":"10","author":"Cos","year":"1991","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0545","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0024-3205(99)00262-3","article-title":"Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro","volume":"65","author":"Mediavilla","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.118934_bb0550","doi-asserted-by":"crossref","unstructured":"S. Garcia-Maurino, M.G. Gonzalez-Haba, J.R. Calvo, R. Goberna, J.M. Guerrero, Involvement of nuclear binding sites for melatonin in the regulation of IL-2 and IL-6 production by human blood mononuclear cells, J. Neuroimmunol.. 92 (1998) 76\u201384, doi:https:\/\/doi.org\/10.1016\/S0165-5728(98)00179-9.","DOI":"10.1016\/S0165-5728(98)00179-9"},{"key":"10.1016\/j.lfs.2020.118934_bb0555","doi-asserted-by":"crossref","unstructured":"S.R. Pandi-Perumal, I. Trakht, V. Srinivasan, D.W. Spence, G.J. Maestroni, N. Zisapel, D.P. Cardinali, Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways, Prog. Neurobiol.. 85 (2008) 335\u2013353, doi:https:\/\/doi.org\/10.1016\/j.pneurobio.2008.04.001.","DOI":"10.1016\/j.pneurobio.2008.04.001"},{"key":"10.1016\/j.lfs.2020.118934_bb0560","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-079X.2009.00684.x","article-title":"Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells","volume":"47","author":"Girgert","year":"2009","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0565","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1038\/sj.onc.1202403","article-title":"BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells","volume":"17","author":"Wang","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2020.118934_bb0570","doi-asserted-by":"crossref","unstructured":"K. Somasundaram, H. Zhang, Y.X. Zeng, Y. Houvras, Y. Peng, H. Zhang, G.S. Wu, J.D. Licht, B.L. Weber, W.S. El-Deiry, Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1\/CiP1, Nature. 389 (1997) 187\u2013190, doi:https:\/\/doi.org\/10.1038\/38291.","DOI":"10.1038\/38291"},{"key":"10.1016\/j.lfs.2020.118934_bb0575","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","article-title":"The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice","volume":"318","author":"Adams","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.118934_bb0580","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.118934_bb0585","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-018-0912-2","article-title":"Recent advances in searching c-Myc transcriptional cofactors during tumorigenesis","volume":"37","author":"Caforio","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0590","doi-asserted-by":"crossref","unstructured":"I. Wierstra, J. Alves, The c-myc promoter: still MysterY and challenge, Adv. Cancer Res.. 99 (2008) 113\u2013333, doi:https:\/\/doi.org\/10.1016\/s0065-230x(07)99004-1.","DOI":"10.1016\/S0065-230X(07)99004-1"},{"key":"10.1016\/j.lfs.2020.118934_bb0595","doi-asserted-by":"crossref","first-page":"a014365","DOI":"10.1101\/cshperspect.a014365","article-title":"MYC degradation","volume":"4","author":"Farrell","year":"2014","journal-title":"Cold Spring Harb Perspect Med."},{"key":"10.1016\/j.lfs.2020.118934_bb0600","doi-asserted-by":"crossref","first-page":"a014423","DOI":"10.1101\/cshperspect.a014423","article-title":"MYC and the control of DNA replication","volume":"4","author":"Dominguez-Sola","year":"2014","journal-title":"Cold Spring Harb Perspect Med."},{"key":"10.1016\/j.lfs.2020.118934_bb0605","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.cell.2010.06.037","article-title":"Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation","volume":"142","author":"Conacci-Sorrell","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118934_bb0610","first-page":"456","article-title":"Melatonin promotes ATO-induced apoptosis in MCF-7 cells: proposing novel therapeutic potential for breast cancer","volume":"83","author":"Nooshinfar","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0615","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ccr.2009.03.021","article-title":"Ablation of key oncogenic pathways by RITA-reactivated p53 is required for efficient apoptosis","volume":"15","author":"Grinkevich","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2020.118934_bb0620","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/sj.onc.1208232","article-title":"hTERT antagonizes p53-induced apoptosis independently of telomerase activity","volume":"24","author":"Rahman","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2020.118934_bb0625","unstructured":"D. Reisman, N.B. Elkind, B. Roy, J. Beamon, V. Rotter, c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif, Cell Growth Differ. 4 (1993) 57\u201365."},{"key":"10.1016\/j.lfs.2020.118934_bb0630","unstructured":"Z. Wang, S. Kyo, M. Takakura, M. Tanaka, N. Yatabe, Y. Maida, M. Fujiwara, J. Hayakawa, M. Ohmichi, K. Koike, M. Inoue, Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway, Cancer Res. 60 (2000) 5376\u201381."},{"key":"10.1016\/j.lfs.2020.118934_bb0635","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/07357907.2011.629378","article-title":"Direct short-term cytotoxic effects of BIBR 1532 on acute promyelocytic leukemia cells through induction of p21 coupled with downregulation of c-Myc and hTERT transcription","volume":"30","author":"Bashash","year":"2012","journal-title":"Cancer Investig."},{"key":"10.1016\/j.lfs.2020.118934_bb0640","unstructured":"S. Dawood, L. Austin, M. Cristofanilli, Cancer stem cells: implications for cancer therapy, Oncology (Williston Park). 28 (2014) 1101\u20137, 1110."},{"key":"10.1016\/j.lfs.2020.118934_bb0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003769","article-title":"c-Myc is required for maintenance of glioma cancer stem cells","volume":"3","author":"Wang","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118934_bb0650","doi-asserted-by":"crossref","unstructured":"A. Wilson, M.J. Murphy, T. Oskarsson, K. Kaloulis, M.D. Bettess, G.M. Oser, A.C. Pasche, C. Knabenhans, H.R. Macdonald, A. Trumpp, c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation, Genes Dev.. 18 (2004) 2747\u201363, doi:https:\/\/doi.org\/10.1101\/gad.313104.","DOI":"10.1101\/gad.313104"},{"key":"10.1016\/j.lfs.2020.118934_bb0655","doi-asserted-by":"crossref","unstructured":"Y. Matsuda, T. Ishiwata, H. Yoshimura, M. Hagio, T. Arai, Inhibition of nestin suppresses stem cell phenotype of glioblastomas through the alteration of post-translational modification of heat shock protein HSPA8\/HSC71, Cancer Lett. 357 (2015) 602\u201311, doi:https:\/\/doi.org\/10.1016\/j.canlet.2014.12.030.","DOI":"10.1016\/j.canlet.2014.12.030"},{"key":"10.1016\/j.lfs.2020.118934_bb0660","doi-asserted-by":"crossref","first-page":"9185","DOI":"10.1128\/MCB.01529-06","article-title":"Profile of histone lysine methylation across transcribed mammalian chromatin","volume":"26","author":"Vakoc","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2020.118934_bb0665","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12496","article-title":"Melatonin disturbs SUMOylation-mediated crosstalk between c-Myc and nestin via MT1 activation and promotes the sensitivity of paclitaxel in brain cancer stem cells","volume":"65","author":"Lee","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0670","doi-asserted-by":"crossref","unstructured":"D. Kim, H.C. Dan, S. Park, L. Yang, Q. Liu, S. Kaneko, J. Ning, L. He, H. Yang, M. Sun, S.V. Nicosia, J.Q. Cheng, AKT\/PKB signaling mechanisms in cancer and chemoresistance, Frontiers in bioscience, Front. Biosci. 10 (2005) 975\u2013987, doi:https:\/\/doi.org\/10.2741\/1592.","DOI":"10.2741\/1592"},{"key":"10.1016\/j.lfs.2020.118934_bb0675","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12380","article-title":"Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K\/AKT and NF-kappaB\/iNOS signaling pathways","volume":"62","author":"Gao","year":"2017","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0680","doi-asserted-by":"crossref","unstructured":"M.H. Hsieh, H.T. Nguyen, Molecular mechanism of apoptosis induced by mechanical forces, Int. Rev. Cytol.. 245 (2005) 45\u201390, doi:https:\/\/doi.org\/10.1016\/s0074-7696(05)45003-2.","DOI":"10.1016\/S0074-7696(05)45003-2"},{"key":"10.1016\/j.lfs.2020.118934_bb0685","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-079X.2009.00682.x","article-title":"Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer","volume":"47","author":"Joo","year":"2009","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0690","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/pros.20457","article-title":"The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells","volume":"66","author":"Hsiang","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.lfs.2020.118934_bb0695","doi-asserted-by":"crossref","unstructured":"J.J. Mukherjee, S.K. Gupta, H. Sikka, S. Kumar, Inhibition of benzopyrene-diol-epoxide (BPDE)-induced bax and caspase-9 by cadmium: role of mitogen activated protein kinase, Mutat. Res.. 661 (2009) 41\u201346, doi:https:\/\/doi.org\/10.1016\/j.mrfmmm.2008.10.020.","DOI":"10.1016\/j.mrfmmm.2008.10.020"},{"key":"10.1016\/j.lfs.2020.118934_bb0700","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-079X.2012.00973.x","article-title":"Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells","volume":"53","author":"Wang","year":"2012","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0705","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.cell.2013.02.016","article-title":"X-inactivation, imprinting, and long noncoding RNAs in health and disease","volume":"152","author":"Lee","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118934_bb0710","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cell.2013.02.012","article-title":"Long noncoding RNAs: cellular address codes in development and disease","volume":"152","author":"Batista","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118934_bb0715","doi-asserted-by":"crossref","first-page":"536","DOI":"10.15252\/embr.201643139","article-title":"Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions","volume":"18","author":"Shen","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.lfs.2020.118934_bb0720","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ijc.30039","article-title":"From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis","volume":"139","author":"Dhamija","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2020.118934_bb0725","doi-asserted-by":"crossref","unstructured":"S. Zeng, Y.F. Xiao, B. Tang, C.J. Hu, R. Xie, S.M. Yang, B.S. Li, Long noncoding RNA in digestive tract cancers: function, mechanism, and potential biomarker, Oncologist. 20 (2015) 898\u2013906, doi:https:\/\/doi.org\/10.1634\/theoncologist.2014-0475.","DOI":"10.1634\/theoncologist.2014-0475"},{"key":"10.1016\/j.lfs.2020.118934_bb0730","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090320","article-title":"Melatonin sensitizes hepatocellular carcinoma cells to chemotherapy through long non-coding RNA RAD51-AS1-mediated suppression of DNA repair","volume":"10","author":"Chen","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2020.118934_bb0735","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12370","article-title":"Cancer metastasis: mechanisms of inhibition by melatonin","volume":"62","author":"Su","year":"2017","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0740","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1093\/nar\/gks270","article-title":"Homologous recombination and its regulation","volume":"40","author":"Krejci","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0745","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cas.12366","article-title":"Targeting DNA damage response in cancer therapy","volume":"105","author":"Hosoya","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lfs.2020.118934_bb0750","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-12-402","article-title":"Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines","volume":"12","author":"Rangwala","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2020.118934_bb0755","doi-asserted-by":"crossref","unstructured":"A.E. Coudert, L. Pibouin, B. Vi-Fane, B.L. Thomas, M. Macdougall, A. Choudhury, B. Robert, P.T. Sharpe, A. Berdal, F. Lezot, Expression and regulation of the Msx1 natural antisense transcript during development, Nucleic Acids Res. 33 (2005) 5208\u20135218, doi:https:\/\/doi.org\/10.1093\/nar\/gki831.","DOI":"10.1093\/nar\/gki831"},{"key":"10.1016\/j.lfs.2020.118934_bb0760","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1073\/pnas.131497098","article-title":"Endogenous Msx1 antisense transcript: in vivo and in vitro evidences, structure, and potential involvement in skeleton development in mammals","volume":"98","author":"Blin-Wakkach","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2020.118934_bb0765","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1038\/sj.onc.1204097","article-title":"Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment","volume":"19","author":"Zucker","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2020.118934_bb0770","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085311","article-title":"Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer","volume":"9","author":"Jardim-Perassi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118934_bb0775","doi-asserted-by":"crossref","unstructured":"R. Roskoski, Jr., Vascular endothelial growth factor (VEGF) signaling in tumor progression, Crit Rev Oncol Hematol. 62 (2007) 179\u2013213, doi:https:\/\/doi.org\/10.1016\/j.critrevonc.2007.01.006.","DOI":"10.1016\/j.critrevonc.2007.01.006"},{"key":"10.1016\/j.lfs.2020.118934_bb0780","doi-asserted-by":"crossref","DOI":"10.3390\/nu9030249","article-title":"Inhibition of VEGF-induced VEGFR-2 activation and HUVEC migration by melatonin and other bioactive Indolic compounds","volume":"9","author":"Cerezo","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2020.118934_bb0785","doi-asserted-by":"crossref","unstructured":"J. Colombo, J.M. Maciel, L.C. Ferreira, D.A.S. RF, D.A. Zuccari, Effects of melatonin on HIF-1alpha and VEGF expression and on the invasive properties of hepatocarcinoma cells, Oncol. Lett.. 12 (2016) 231\u2013237, doi:https:\/\/doi.org\/10.3892\/ol.2016.4605.","DOI":"10.3892\/ol.2016.4605"},{"key":"10.1016\/j.lfs.2020.118934_bb0790","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/jpi.12142","article-title":"Antitumour activity of melatonin in a mouse model of human prostate cancer: relationship with hypoxia signalling","volume":"57","author":"Paroni","year":"2014","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0795","doi-asserted-by":"crossref","unstructured":"J.H.M. Marques, A.L. Mota, J.G. Oliveira, J.Z. Lacerda, J.P. Stefani, L.C. Ferreira, T.B. Castro, A.F. Aristiz\u00e1bal-Pach\u00f3n, D.A.P.C. Zuccari, Melatonin restrains angiogenic factors in triple-negative breast cancer by targeting miR-152-3p: in vivo and in vitro studies, Life Sci.. 208 (2018) 131\u2013138, doi:https:\/\/doi.org\/10.1016\/j.lfs.2018.07.012.","DOI":"10.1016\/j.lfs.2018.07.012"},{"key":"10.1016\/j.lfs.2020.118934_bb0800","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/bjc.2013.285","article-title":"Inhibition of VEGF expression through blockade of Hif1alpha and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells","volume":"109","author":"Carbajo-Pescador","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2020.118934_bb0805","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-079X.2009.00742.x","article-title":"Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia","volume":"48","author":"Park","year":"2010","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0810","doi-asserted-by":"crossref","unstructured":"W.G. Kaelin, Jr., The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer, Nat. Rev. Cancer. 8 (2008) 865\u201373, doi:https:\/\/doi.org\/10.1038\/nrc2502.","DOI":"10.1038\/nrc2502"},{"key":"10.1016\/j.lfs.2020.118934_bb0815","doi-asserted-by":"crossref","unstructured":"Y. Zhang, Q. Liu, F. Wang, E.A. Ling, S. Liu, L. Wang, Y. Yang, L. Yao, X. Chen, F. Wang, W. Shi, M. Gao, A. Hao, Melatonin antagonizes hypoxia-mediated glioblastoma cell migration and invasion via inhibition of HIF-1alpha, J. Pineal Res. 55 (2013) 121\u201330, doi:https:\/\/doi.org\/10.1111\/jpi.12052.","DOI":"10.1111\/jpi.12052"},{"key":"10.1016\/j.lfs.2020.118934_bb0820","doi-asserted-by":"crossref","unstructured":"J. Cheng, H.L. Yang, C.J. Gu, Y.K. Liu, J. Shao, R. Zhu, Y.Y. He, X.Y. Zhu, M.Q. Li, Melatonin restricts the viability and angiogenesis of vascular endothelial cells by suppressing HIF-1\u03b1\/ROS\/VEGF, Int. J. Mol. Med. 43 (2019) 945\u2013955, doi:https:\/\/doi.org\/10.3892\/ijmm.2018.4021.","DOI":"10.3892\/ijmm.2018.4021"},{"key":"10.1016\/j.lfs.2020.118934_bb0825","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-079X.2011.00865.x","article-title":"Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1alpha inactivation in hypoxic PC-3 prostate cancer cells","volume":"51","author":"Cho","year":"2011","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0830","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3892\/ol.2016.4729","article-title":"Melatonin downregulates nuclear receptor RZR\/RORgamma expression causing growth-inhibitory and anti-angiogenesis activity in human gastric cancer cells in vitro and in vivo","volume":"12","author":"Wang","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2020.118934_bb0835","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/ijms18040763","article-title":"Melatonin reduces angiogenesis in serous papillary ovarian carcinoma of ethanol-preferring rats","volume":"18","author":"Zonta","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2020.118934_bb0840","doi-asserted-by":"crossref","unstructured":"A. GONz\u00e1LEz-GONz\u00e1LEz, A. Gonz\u00e1lez, C. Alonso-Gonz\u00e1lez, J. MEN\u00e9NdEz-MEN\u00e9NdEz, C. Mart\u00ednez-Campa, S. Cos, Complementary actions of melatonin on angiogenic factors, the angiopoietin\/Tie2 axis and VEGF, in co-cultures of human endothelial and breast cancer cells, Oncol. Rep.. 39 (2018) 433\u2013441, doi:https:\/\/doi.org\/10.3892\/or.2017.6070.","DOI":"10.3892\/or.2017.6070"},{"key":"10.1016\/j.lfs.2020.118934_bb0845","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-015-0454-8","article-title":"Involvement of ROS-alpha v beta 3 integrin-FAK\/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia","volume":"13","author":"Xu","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lfs.2020.118934_bb0850","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00432-011-1024-y","article-title":"Overexpression of osteopontin and integrin \u03b1v in laryngeal and hypopharyngeal carcinomas associated with differentiation and metastasis","volume":"137","author":"Lu","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.lfs.2020.118934_bb0855","doi-asserted-by":"crossref","unstructured":"D. Du, F. Xu, L. Yu, C. Zhang, X. Lu, H. Yuan, Q. Huang, F. Zhang, H. Bao, L. Jia, X. Wu, X. Zhu, X. Zhang, Z. Zhang, Z. Chen, The tight junction protein, occludin, regulates the directional migration of epithelial cells, Dev. Cell. 18 (2010) 52\u201363, doi:https:\/\/doi.org\/10.1016\/j.devcel.2009.12.008.","DOI":"10.1016\/j.devcel.2009.12.008"},{"key":"10.1016\/j.lfs.2020.118934_bb0860","article-title":"Melatonin inhibits the migration of human lung adenocarcinoma A549 cell lines involving JNK\/MAPK pathway","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118934_bb0865","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajpath.2011.09.008","article-title":"An alternate perspective on the roles of TIMPs and MMPs in pathology","volume":"180","author":"Moore","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2020.118934_bb0870","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12370","article-title":"Cancer metastasis: mechanisms of inhibition by melatonin","volume":"62","author":"Su","year":"2017","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0875","doi-asserted-by":"crossref","unstructured":"C. Min, S.F. Eddy, D.H. Sherr, G.E. Sonenshein, NF-kappaB and epithelial to mesenchymal transition of cancer, J. Cell. Biochem. 104 (2008) 733\u2013744, doi:https:\/\/doi.org\/10.1002\/jcb.21695.","DOI":"10.1002\/jcb.21695"},{"key":"10.1016\/j.lfs.2020.118934_bb0880","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-079X.2008.00600.x","article-title":"ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration","volume":"46","author":"Ort\u00edz-L\u00f3pez","year":"2009","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0885","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/jpi.12308","article-title":"Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-kappaB DNA-binding activity","volume":"60","author":"Lin","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0890","first-page":"50","article-title":"Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in chemotherapy-pretreated patients with advanced lung adenocarcinoma and low performance status","volume":"22","author":"Norsa","year":"2007","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.lfs.2020.118934_bb0895","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1034\/j.1600-079X.2003.00032.x","article-title":"Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial","volume":"35","author":"Lissoni","year":"2003","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.118934_bb0900","unstructured":"A. Sookprasert, N.P. Johns, A. Phunmanee, P. Pongthai, A. Cheawchanwattana, J. Johns, J. Konsil, P. Plaimee, S. Porasuphatana, S. Jitpimolmard, Melatonin in patients with cancer receiving chemotherapy: a randomized, double-blind, placebo-controlled trial, Anticancer Res. 34 (2014) 7327\u20137337."},{"key":"10.1016\/j.lfs.2020.118934_bb0905","unstructured":"G. Cerea, M. Vaghi, A. Ardizzoia, S. Villa, R. Bucovec, S. Mengo, G. Gardani, G. Tancini, P. Lissoni, Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations, Anticancer Res. 23 (2003) 1951\u20131954."},{"key":"10.1016\/j.lfs.2020.118934_bb0910","unstructured":"P. Lissoni, F. Malugani, R. Bukovec, V. Bordin, M. Perego, S. Mengo, A. Ardizzoia, G. Tancini, Reduction of cisplatin-induced anemia by the pineal indole 5-methoxytryptamine in metastatic lung cancer patients, Neuroendocrinol. Lett. 24. (2003) 83\u201385."},{"key":"10.1016\/j.lfs.2020.118934_bb0915","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.nut.2004.05.026","article-title":"Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study","volume":"21","author":"Persson","year":"2005","journal-title":"Nutrition"},{"key":"10.1016\/j.lfs.2020.118934_bb0920","unstructured":"P. Lissoni, F. Rovelli, F. Brivio, L. Fumagalli, G. Brera, A study of immunoendocrine strategies with pineal indoles and interleukin-2 to prevent radiotherapy-induced lymphocytopenia in cancer patients, in vivo. 22 (2008) 397\u2013400."},{"key":"10.1016\/j.lfs.2020.118934_bb0925","doi-asserted-by":"crossref","unstructured":"N.K. Habibi, A.S. Monfared, K.E. Gorji, M. Karimi, A. Moghadamnia, M. Tourani, S. Borzoueisileh, F. Niksirat, The protective effects of melatonin on blood cell counts of rectal cancer patients following radio-chemotherapy: a randomized controlled trial, Clin. Transl. Oncol.. 21 (2019) 745\u2013752, doi:https:\/\/doi.org\/10.1007\/s12094-018-1977-2.","DOI":"10.1007\/s12094-018-1977-2"},{"key":"10.1016\/j.lfs.2020.118934_bb0930","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/odi.13265","article-title":"Efficacy of melatonin in prevention of radiation-induced oral mucositis: a randomized clinical trial","volume":"26","author":"Elsabagh","year":"2020","journal-title":"Oral Dis."},{"key":"10.1016\/j.lfs.2020.118934_bb0935","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231379","article-title":"Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Palmer","year":"2020","journal-title":"PLoS One"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520316945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520316945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T06:52:04Z","timestamp":1710399124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520316945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":187,"alternative-id":["S0024320520316945"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118934","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic targets of cancer drugs: Modulation by melatonin","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118934","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118934"}}